← Leaderboards
Esther Kim Kemper
Scripps Research Institute, The
$97,572
Attributed
$97,572
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $33K · FY2019–21$50K$37.5K$25K$12.5K$0
'19
'20
'21
Funding mix
By agency
NIH$97,572 · 1
By mechanism
F31$97,572 · 1
Top collaborators
No co-investigators on record.
Most similar at Scripps Research Institute, The
Same institution · by research overlap
- Daniel Nomura$13,467,439
- Dale L Boger$41,942,040
- Enrique Saez$14,086,731
- Jin-Quan Yu$14,956,760
- Brent Randall Martin$3,209,476
Others in their field
Other Emerging Leaders on “Drug Resistance”
- John Damon Chodera · Sloan-Kettering Inst Can Research$58,448,823
- Nancy Roche · Leidos Biomedical Research, Inc.$39,999,252
- Michael Dignam · National Institute Of Allergy And Infectious Diseases$30,845,607
- Olwen Hahn · Brigham And Women'S Hospital$23,582,395
- Ryan Cirz · Revagenix, Inc.$22,711,751
- Bruce Blough · Research Triangle Institute$19,637,160
Research focus
Drug ResistanceDrug SensitivityAntineoplastic AgentsActivity-Based Protein ProfilingBaseCancer CellBiochemicalCancer TherapyCdk4 GeneBiological SystemsBreast Cancer CellCellsChemoproteomicsClinicCollaborationsCancer Drug ResistanceComplexCyclin D1Cyclin-Dependent Kinase InhibitorCyclin-Dependent KinasesCysteineCell CycleCell LineDrug Targeting
Grant awards (3)
Elucidating the mechanisms of CDK inhibitor resistance in cancer using chemical proteomics$33,036
F31 · FY2021 · CA · contact PI
Elucidating the mechanisms of CDK inhibitor resistance in cancer using chemical proteomics$32,520
F31 · FY2020 · CA · contact PI
Elucidating the mechanisms of CDK inhibitor resistance in cancer using chemical proteomics$32,016
F31 · FY2019 · CA · contact PI